We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-0.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$72.2B
AUM Growth
-$2.06B
Cap. Flow
-$1B
Cap. Flow %
-1.39%
Top 10 Hldgs %
13.59%
Holding
772
New
75
Increased
223
Reduced
376
Closed
50

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$779M
2
ATVI
Activision Blizzard
ATVI
+$679M
3
CVS icon
CVS Health
CVS
+$459M
4
ETN icon
Eaton
ETN
+$221M
5
CI icon
Cigna
CI
+$209M

Sector Composition

Rank Sector Weight
1 Financials 18.31%
2 Industrials 16.74%
3 Technology 14.67%
4 Healthcare 13.36%
5 Consumer Discretionary 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$942B
$1.35B 1.87%
9,308,422
+48,957
+0.5% +$7.34M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.17T
$1.15B 1.59%
8,795,108
-236,610
-3% -$30.6M
AZO icon
3
AutoZone
AZO
$47.9B
$1.09B 1.51%
430,999
-6,134
-1% -$15.4M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.01B 1.4%
2,897,423
-59,300
-2% -$21M
BMY icon
5
Bristol-Myers Squibb
BMY
$137B
$1,000M 1.38%
17,314,588
-89,166
-0.5% -$5.46M
CSCO icon
6
Cisco
CSCO
$442B
$930M 1.29%
17,322,198
-1,812,014
-9% -$97.8M
COR icon
7
Cencora
COR
$61.3B
$886M 1.23%
4,919,109
-49,735
-1% -$9.19M
HAL icon
8
Halliburton
HAL
$29.6B
$876M 1.21%
21,650,224
-4,098,530
-16% -$161M
SLB icon
9
SLB Ltd
SLB
$81.6B
$778M 1.08%
13,368,853
-1,992,450
-13% -$116M
DFS
10
DELISTED
Discover Financial Services
DFS
$744M 1.03%
8,597,250
+3,102,119
+56% +$308M
HWM icon
11
Howmet Aerospace
HWM
$107B
$739M 1.02%
16,007,374
-1,434,613
-8% -$69.9M
USFD icon
12
US Foods
USFD
$23.3B
$727M 1.01%
18,313,484
+257,503
+1% +$10.7M
CPAY icon
13
Corpay
CPAY
$26.5B
$715M 0.99%
2,808,106
-178,373
-6% -$46.6M
ICLR icon
14
Icon
ICLR
$13.1B
$711M 0.98%
2,886,827
-214,162
-7% -$54M
UNH icon
15
UnitedHealth
UNH
$355B
$705M 0.98%
1,394,005
-27,763
-2% -$13.7M
SNY icon
16
Sanofi
SNY
$107B
$681M 0.94%
12,787,064
-327,638
-2% -$17.5M
MPC icon
17
Marathon Petroleum
MPC
$102B
$680M 0.94%
4,496,777
-686,047
-13% -$95.6M
CVE icon
18
Cenovus Energy
CVE
$58.5B
$677M 0.94%
29,412,644
+2,325,082
+9% +$44.4M
WFC icon
19
Wells Fargo
WFC
$257B
$651M 0.9%
15,949,825
-2,306,243
-13% -$99.6M
DELL icon
20
Dell
DELL
$305B
$646M 0.89%
9,378,447
-404,796
-4% -$24.1M
CB icon
21
Chubb
CB
$131B
$594M 0.82%
2,850,197
+170,774
+6% +$34.5M
GPN icon
22
Global Payments
GPN
$24.5B
$592M 0.82%
5,142,771
+1,481,714
+40% +$176M
AVTR icon
23
Avantor
AVTR
$9.88B
$588M 0.81%
28,077,026
+4,948,951
+21% +$105M
ALLE icon
24
Allegion
ALLE
$13.6B
$584M 0.81%
5,613,219
+825,048
+17% +$92.9M
CCEP icon
25
Coca-Cola Europacific Partners
CCEP
$47.4B
$582M 0.81%
9,326,137
-299,786
-3% -$19.1M

Similar funds

Boston Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Boston Partners held 772 positions worth $72.2B, down 2.8% from $74.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boston Partners's Q3 2023 filing shows 75 new, 223 increased, 376 reduced and 50 closed positions. Its largest new stake was Morgan Stanley: 5,899,130 shares worth $478M. The largest sale was Johnson & Johnson, an estimated $779M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Partners's largest Q3 2023 buy was Morgan Stanley: 5,899,130 shares worth $478M.
  • Boston Partners added most to Discover Financial Services in Q3 2023, an estimated $308M increase.
  • Boston Partners's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $779M.
  • Boston Partners fully exited Western Digital in Q3 2023, selling an estimated $80.2M.
  • Boston Partners's ten largest holdings make up 14% of its $72.2B portfolio in Q3 2023.
  • Boston Partners opened 75 new positions and closed 50 in Q3 2023.
  • Boston Partners's portfolio value fell 2.8% quarter-over-quarter to $72.2B.

Based on Boston Partners's 13F filing for Q3 2023, filed 8 Nov 2023.